Author:
Hufnagel Stephanie,Xu Haiyue,Sahakijpijarn Sawittree,Moon Chaeho,Chow Laura Q.M.,Williams III Robert O.,Cui Zhengrong
Reference52 articles.
1. Agarabi, C., 2006. Identification and Minimization of Protein Loss During the Manufacturing of a Beta Domain Deleted Recombinant Human Factor VIII.
2. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody1;Andya;Pharm. Res.,1999
3. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement;Baughman;Am. J. Respir. Crit. Care Med.,2006
4. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice;Beinborn;Eur J Pharm Biopharm,2012
5. Lyophilization strategies for development of a high-concentration monoclonal antibody formulation: benefits and pitfalls;Bhambhani;Am Pharm Rev,2010
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献